Published by Josh White on 10th January 2022
(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.
URL: http://www.digitallook.com/dl/news/story/32381569/...